🔎 Trials Near Me

Akèy › Hyperaldostéronisme

Etid klinik pou Hyperaldostéronisme ap rekrite nan Etazini

5 etid pou Hyperaldostéronisme ap rekrite patisipan nan sit atravè Etazini.

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 a 70 · Tout sèks · Mizajou Sep 16, 2026 · NCT03374215

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 0 a 20 · Tout sèks · Mizajou Aug 21, 2026 · NCT04278404

A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT07007793

Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study

Ap rekriteFaz 4
Laj 18 a 85 · Tout sèks · Mizajou Feb 7, 2025 · NCT05030545

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.